| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.
|
Gastroenterology
|
2012
|
2.68
|
|
2
|
Management of Barrett's esophagus in the UK: overtreated and underbiopsied but improved by the introduction of a national randomized trial.
|
Am J Gastroenterol
|
2008
|
2.52
|
|
3
|
Mechanisms of field cancerization in the human stomach: the expansion and spread of mutated gastric stem cells.
|
Gastroenterology
|
2007
|
2.39
|
|
4
|
Barrett's metaplasia glands are clonal, contain multiple stem cells and share a common squamous progenitor.
|
Gut
|
2011
|
1.77
|
|
5
|
A phase II study of gefitinib monotherapy in advanced esophageal adenocarcinoma: evidence of gene expression, cellular, and clinical response.
|
Clin Cancer Res
|
2007
|
1.28
|
|
6
|
Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action.
|
Oncogene
|
2002
|
1.25
|
|
7
|
The clonal origins of dysplasia from intestinal metaplasia in the human stomach.
|
Gastroenterology
|
2011
|
1.05
|
|
8
|
Identification of lineage-uncommitted, long-lived, label-retaining cells in healthy human esophagus and stomach, and in metaplastic esophagus.
|
Gastroenterology
|
2012
|
1.05
|
|
9
|
Perceptions of malaria and acceptance of rapid diagnostic tests and related treatment practises among community members and health care providers in Greater Garissa, North Eastern Province, Kenya.
|
Malar J
|
2014
|
1.04
|
|
10
|
Glycosylation of {beta}2 subunits regulates GABAA receptor biogenesis and channel gating.
|
J Biol Chem
|
2010
|
1.02
|
|
11
|
A naturalistic study of predictors and risks of atypical antipsychotic use in an attention-deficit/hyperactivity disorder clinic.
|
J Child Adolesc Psychopharmacol
|
2009
|
1.00
|
|
12
|
Mass spectrometric analysis of mutant mice.
|
Methods Enzymol
|
2010
|
0.99
|
|
13
|
Ectopic expression of P-cadherin correlates with promoter hypomethylation early in colorectal carcinogenesis and enhanced intestinal crypt fission in vivo.
|
Cancer Res
|
2008
|
0.96
|
|
14
|
Electronic cigarette explosions involving the oral cavity.
|
J Am Dent Assoc
|
2016
|
0.95
|
|
15
|
Bushido and medical professionalism in Japan.
|
Acad Med
|
2014
|
0.93
|
|
16
|
Cytoplasmic beta-catenin accumulation is a good prognostic marker in upper and lower gastrointestinal adenocarcinomas.
|
Histopathology
|
2010
|
0.93
|
|
17
|
Met receptor signaling: a key effector in esophageal adenocarcinoma.
|
Clin Cancer Res
|
2006
|
0.89
|
|
18
|
Endothelial galectin-1 binds to specific glycans on nipah virus fusion protein and inhibits maturation, mobility, and function to block syncytia formation.
|
PLoS Pathog
|
2010
|
0.88
|
|
19
|
Clinicians didn't reliably distinguish between different causes of cardiac death using case histories.
|
J Clin Epidemiol
|
2006
|
0.86
|
|
20
|
Survey of overnight academic hospitalist supervision of trainees.
|
J Hosp Med
|
2012
|
0.86
|
|
21
|
Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.
|
Am J Gastroenterol
|
2015
|
0.84
|
|
22
|
Identification of novel contributions to high-affinity glycoprotein-receptor interactions using engineered ligands.
|
J Mol Biol
|
2009
|
0.81
|
|
23
|
NSAID and oesophageal adenocarcinoma: randomised trials needed to correct for bias.
|
Lancet Oncol
|
2006
|
0.76
|
|
24
|
Progress in the development of small molecule therapeutics targeting Th17 cell function for the treatment of immune-inflammatory diseases.
|
Prog Med Chem
|
2011
|
0.76
|